Susquehanna International Group, LLP Tenaya Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 146,762 shares of TNYA stock, worth $139,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,762
Previous 10,339
1319.5%
Holding current value
$139,423
Previous $19,000
1000.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TNYA
# of Institutions
93Shares Held
55.6MCall Options Held
900Put Options Held
104K-
Column Group LLC San Francisco, CA9.4MShares$8.93 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$6.4 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$4.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$3.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.11 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $39.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...